Chromenopyridine Derivatives as Novel 6PGD Inhibitors, MD Simulation, and Antioxidant Capacities
Journal of Chemistry · 2026-01 · 2026 (1)
DOI: 10.1155/joch/3470321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemistry, online erschienen am 19.03.2026. Verfasst von Arzu Ozturk Kesebır und 2 weiteren Autor:innen. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştirma Kurumu.
Abstract (Originalsprache)
This study investigated the inhibitory effects of chromeno[4,3‐b]pyridine‐benzisoxazole derivatives on 6‐phosphogluconate dehydrogenase (6PGD), an important target enzyme in cancer treatment. In vitro analyses determined K i values of 1.77 μM and 2.21 μM for Compounds 1 and 2, respectively. Complementary in silico studies revealed that Compound 1 exhibited the strongest inhibitory activity, with a calculated binding free energy of −10.27 kcal/mol. Molecular dynamics simulations (100 ns) confirmed the structural stability of the enzyme–ligand complex, and free energy surface analysis showed a single dominant thermodynamic equilibrium state reflecting high conformational stability. MM/PBSA binding free energy calculations yielded a total energy of −26.78 ± 0.62 kJ/mol, indicating that the interaction is primarily stabilized by van der Waals and electrostatic forces. Additionally, antioxidant tests conducted using 10 different methods showed that chromeno[4,3‐b]pyridine‐benzisoxazole derivatives have better antioxidant capacity compared to reference anticancer drugs. When these findings are considered together, it appears that chromeno[4,3‐b]pyridine‐benzisoxazole derivatives are effective, stable, and promising 6PGD inhibitors.
Förderung
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
Zitieren
APA
Kesebır, A. O., Akıncıoglu, H., & Comaklı, V. (2026). Chromenopyridine Derivatives as Novel 6PGD Inhibitors, MD Simulation, and Antioxidant Capacities. Journal of Chemistry, 2026(1). https://doi.org/10.1155/joch/3470321
Vancouver
Kesebır AO, Akıncıoglu H, Comaklı V. Chromenopyridine Derivatives as Novel 6PGD Inhibitors, MD Simulation, and Antioxidant Capacities. Journal of Chemistry. 2026;2026(1). doi:10.1155/joch/3470321
BibTeX
@article{Kesebr2026,
author = {Kesebır, Arzu Ozturk and Akıncıoglu, Hülya and Comaklı, Veysel},
title = {Chromenopyridine Derivatives as Novel 6PGD Inhibitors, MD Simulation, and Antioxidant Capacities},
journal = {Journal of Chemistry},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/joch/3470321}
}
EUVIMED